» Articles » PMID: 20221774

Novel Compound Heterozygous ATP6V0A4 Mutations in an Infant with Distal Renal Tubular Acidosis

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2010 Mar 12
PMID 20221774
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A Japanese infant presenting with vomiting, failure to thrive, metabolic acidosis, and hyperammonemia was finally diagnosed with autosomal recessive distal renal tubular acidosis (dRTA). Hyperchloremic metabolic acidosis, hypokalemia, a normal serum anion gap, a positive urine anion gap, nephrocalcinosis, and high urine pH despite systemic acidemia were consistent with the cardinal manifestations in dRTA. Mutational analysis of the ATP6V0A4 gene revealed novel compound heterozygous mutations: Ile549fsX580 and Ile557Leu558del. The father was found to be heterozygote for the former mutation, the mother heterozygote for the latter. This is the first case of dRTA with hyperammonemia in which the ATP6V0A4 mutations were identified. dRTA should be considered in the differential diagnosis of children presenting with hyperammonemia. Additionally, in a possible case of autosomal recessive dRTA with normal hearing, mutational analysis of ATP6V0A4 gene may be recommended first to confirm the diagnosis.

Citing Articles

Hyperammonemic encephalopathy requiring hemodialysis in a child with distal renal tubular acidosis.

Huseynli B, Akkuzu E, Buyukkaragoz B, Bakkaloglu S J Nephrol. 2025; .

PMID: 39915375 DOI: 10.1007/s40620-025-02218-4.


Molecular Aspects of Distal Kidney Tubular Acidosis in Children, Its Long-Term Outcome, and Relationship with Hyperammonemia.

Guven S, Gokce I, Alavanda C, Ozturk Hismi B, Cicek N, Demirci E Turk Arch Pediatr. 2022; 57(4):432-440.

PMID: 35822476 PMC: 9366285. DOI: 10.5152/TurkArchPediatr.2022.21362.


Endolymphatic sac enlargement in an infant with metabolic acidosis.

Leventoglu E, Fidan K, Girgin C, Yazol M, Varol S, Soylemezoglu O J Nephrol. 2021; 35(1):333-335.

PMID: 34086198 DOI: 10.1007/s40620-021-01085-z.


Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.

Bertholet-Thomas A, Guittet C, Manso-Silvan M, Castang A, Baudouin V, Cailliez M Pediatr Nephrol. 2020; 36(1):83-91.

PMID: 32712761 PMC: 7701073. DOI: 10.1007/s00467-020-04693-2.


A novel homozygous deletion in ATP6V0A4 causes distal renal tubular acidosis: A case report.

Yuan J, Huang K, Wu W, Zhang L, Dong G Medicine (Baltimore). 2019; 98(30):e16504.

PMID: 31348261 PMC: 6709018. DOI: 10.1097/MD.0000000000016504.


References
1.
Stover E, Borthwick K, Bavalia C, Eady N, Fritz D, Rungroj N . Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J Med Genet. 2002; 39(11):796-803. PMC: 1735017. DOI: 10.1136/jmg.39.11.796. View

2.
Pela I, Seracini D . Hyperammonemia in distal renal tubular acidosis: is it more common than we think?. Clin Nephrol. 2007; 68(2):109-14. DOI: 10.5414/cnp68109. View

3.
Smith A, Skaug J, Choate K, Nayir A, Bakkaloglu A, Ozen S . Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet. 2000; 26(1):71-5. DOI: 10.1038/79208. View

4.
Bruce L, Cope D, Jones G, Schofield A, Burley M, Povey S . Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997; 100(7):1693-707. PMC: 508352. DOI: 10.1172/JCI119694. View

5.
Rodriguez Soriano J . Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002; 13(8):2160-70. DOI: 10.1097/01.asn.0000023430.92674.e5. View